Correlation Engine 2.0
Clear Search sequence regions

  • AK 1 (1)
  • AMPK (2)
  • Bcl 2 (1)
  • curcumin (1)
  • death rates (1)
  • Drp1 (1)
  • end- stage renal disease (1)
  • ERK (2)
  • homeostasis (1)
  • humans (1)
  • IL 1β (1)
  • IL 6 (1)
  • mTOR (2)
  • NF κB (1)
  • NRF2 (1)
  • OPA1 (1)
  • pathogenesis (1)
  • PGC 1α (1)
  • renal diseases (1)
  • research (3)
  • resveratrol (1)
  • signal (1)
  • SIRT1 (2)
  • SIRT2 (1)
  • SIRT3 (1)
  • sirtuins (18)
  • thujaplicins (1)
  • TNF α (1)
  • Sizes of these terms reflect their relevance to your search.

    Acute kidney injury (AKI), a common multidisciplinary diagnostic clinical critical illness, eventually causes end-stage renal disease (ESRD). Although many clinical measures have been taken to prevent or treat AKI, high morbidity and death rates were recorded. Therefore, in-depth pathogenesis study and search for new therapeutic targets are in demand. Interestingly, the suirtuins family showed a significant protective effect in AKI. Sirtuins (SIRT1-7) is a family of seven proteins with NAD+-dependent type III histone deacetylase activity. Sirtuins family members were involved by AKI, and regulation of sirtuins activities significantly improved AKI-induced renal injury. Therefore, the therapeutic role and molecular mechanisms of the sirtuins family in AKI has important research implications for clinical applications or basic research. This review summarizes recent advances in the roles and functions of the sirtuins family, discusses their therapeutic effects on AKI and related molecular mechanisms, and the mechanisms of action of small molecule specific activators or inhibitors sirtuins in the prevention and treatment of AKI were discussed. The data in this review were retrieved from various scientific databases (PubMed, Google scholar, Science Direct, and Web of Science), till December 2021. The keywords were used as follows: "Sirtuins", "Acute kidney injury", "AKI", "Sirtuins modulators" and "Histone deacetylation". The retrieved data followed PRISMA criteria (preferred reporting items for systematic review). Growing evidence indicates that members of the sirtuins family regulate the development and progression of different renal diseases, including AKI, through anti-inflammation, antioxidation, anti-apoptotic, and maintenance of mitochondrial homeostasis. The molecular mechanism of Sirtuins family on AKI mainly regulated NF-κB, JNK/ERK, and AMPK/mTOR signaling pathways, upregulated the expression of PGC-1α, HO-1, NRF2, Bcl-2, OPA1, and AMPK, and downregulated the expression of NRLP3, IL-1β, TNF-α, IL-6, ROS, MFF, Drp1, Bax, ERK, and mTOR. In addition, the active ingredients of herbs (resveratrol, thujaplicins, huperzine, and curcumin) could activate the activity of SIRT1 or SIRT3, thereby improving AKI. Meanwhile, the synthetic Sirtuins inhibitor (AK-1) inhibited SIRT2 activity, thus alleviating AKI. In the future, more specific modulators will remain needed to enhance the clinical therapeutic role of the Sirtuins family in AKI. The sirtuins family is a promising type III histone deacetylase for AKI treatment. This review will provide insight into sirtuins family's therapeutic role in AKI and promote the clinical use of sirtuins modulators in AKI. Copyright © 2022 Elsevier GmbH. All rights reserved.


    Chaoming Huang, Shisheng Jiang, Shuhan Gao, Yuxin Wang, Xiaoting Cai, Junyan Fang, Tingdong Yan, Chunpeng Craig Wan, Yi Cai. Sirtuins: Research advances on the therapeutic role in acute kidney injury. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2022 Jul;101:154122

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 35490494

    View Full Text